Press & Media

SkinMedica to Present at the Leerink Swann "Hot Topics in Therapeutics" Roundtable Conference

CARLSBAD, CA - February 10, 2011 - SkinMedica, Inc. today announced that the Company’s CEO, Mary Fisher, will present at the upcoming Leerink Swann “Hot Topics in Therapeutics” Roundtable Conference on Thursday, February 17, 2011 at 2:00pm ET at the Roosevelt Hotel in New York City. Mary Fisher will also participate in an Aesthetics panel on Thursday at 4:00pm ET.

###

About SkinMedica

SkinMedica, Inc. is focused on developing, acquiring, and commercializing products that improve the appearance of skin. SkinMedica markets and sells to physicians, with a focus on aesthetics, both prescription and non-prescription skin care products. The company's full line of aesthetic skin care products includes the revolutionary TNS Essential Serum® and hallmark TNS Recovery Complex®. The formulations in SkinMedica’s clinical skin care collection enhance skin appearance, reduce signs of aging, and provide other skin care benefits. SkinMedica's primary prescription product, VANIQA® (eflornithine hydrochloride) Cream 13.9%, is the only FDA-approved prescription product for the reduction of unwanted facial hair in women. Colorescience Pro’s dermatologist recommended, high-performance cosmetics are formulated to remedy and camouflage specific skin concerns and protect skin from damaging effects of the sun and environment. Colorescience Pro’s luxury aesthetic makeup line is sold in the physician and medical spa channels.

TNS Recovery Complex®, VANIQA®, and SkinMedica®, are registered trademarks of SkinMedica, Inc and affiliates.